MedTrace Logo

e-BioMatrix 6 Month DAPT France

NCT03461484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2098

Last updated 2020-04-15

No results posted yet for this study

Summary

Prospective, multi-center observational study to be conducted in up to 30 French interventional cardiology centers. The purpose of this observational study is to capture, in French Centers, clinical data of the BioMatrix Flex™ and BioMatrix NeoFlex™ Drug Eluting Coronary Stents System (Biolimus A9, BA9™-) in normal practice, in patients treated with 6-month DAPT, and to compare the outcomes to those of previous e-biomatrix registries with longer DAPT durations. The patients will be followed up for 2 years for data collection.

Conditions

  • Coronary Artery Stenoses
  • Stable Angina
  • Ischemia
  • NSTEMI - Non-ST Segment Elevation MI
  • STEMI

Sponsors & Collaborators

  • European Cardiovascular Research Center

    collaborator NETWORK

  • Biosensors Europe SA

    lead INDUSTRY

Principal Investigators

  • Christian Spaulding, MD · Hôpital Européen Georges-Pompidou

  • Lanusz Lipiecki, MD · Clinique des Dômes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-06
Primary Completion
2018-04-09
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03461484 on ClinicalTrials.gov